In a 2019 study published in Cell Tissue Research , researchers noted, it is apparent that BPC 157 has huge potential and, following further development, has promise as a therapy to conservatively treat or aid recovery in hypovascular and hypocellular soft tissues such as tendon and ligaments . Neurological conditions result in brain fog, memory loss, and concussion
For patients with obesity-related comorbidities such as hypertension, dyslipidaemia, or fatty liver disease these combined effects could represent a clinically meaningful advance if confirmed in Phase 3 data
Remember, this dose is based on medical advice
With the specialized handpiece, Dr
Larazotide (AT-1001), an octapeptide that regulates gut tight junction function and prevents pathological increases in gut permeability